Trodelvy 180 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9GH7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,669
Award facts
- Contract value 100% obligated
- $33,669.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,669.00 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials. The contract, designated as a firm fixed price delivery order with no set-aside designation, carries an ultimate completion date of January 9, 2026. This award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor supporting military and veteran healthcare systems.
Trodelvy (sacituzumab govitecan) is a targeted cancer therapy used in the treatment of specific malignancies, consistent with AmerisourceBergen's role in supplying specialty medications and brand-name pharmaceuticals across multiple therapeutic domains. The delivery order will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This award demonstrates AmerisourceBergen's continued capability to meet federal medical supply requirements through competitive procurement, adding to its extensive portfolio of pharmaceutical deliveries supporting Department of Defense healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26F9GH7?
SPE2DR26F9GH7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9GH7 worth?
The government has obligated $33,669 on SPE2DR26F9GH7.
Is contract SPE2DR26F9GH7 an order under another contract?
Yes. SPE2DR26F9GH7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GH7 competed?
The extent of competition for SPE2DR26F9GH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award